返回 Agenda
Session 5: Facilitating Access to Innovation in Asia / Practical pragmatic approaches
Session Chair(s)
Thean Soo Lo
Regulatory Affairs Management Consultant, Singapore
Audrey Ooi, MSc
Head- Business Development
Clinical Research Malaysia, Malaysia
Speaker(s)
Facilitating Regulatory Collaboration to Speed up Patient Access - Industry Perspective
Angelika Joos, MPharm
MSD, Belgium
Executive Director, Global Regulatory Policy
Support for Innovation and Accelerated access
Wittawat Viriyabancha
Thai Food and Drug Administration, Thailand
Pharmacist Professional Level, Pre-Marketing Control Division,
Re-imaging the Regulatory Paradigm for Digital Health
Lesley Maloney, PharmD
Genentech, A Member of the Roche Group, United States
Global Regulatory Policy Lead - Digital Health and Integrated Solutions
PMDA’s Activities to Promote Rapid Patient Access
Mari Shirotani, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office Director, Office of Advanced Evaluation with Electronic Data
Data Analytics for Active Surveillance
Cynthia Sung Ang, MPH, RPh
Health Sciences Authority, Singapore
Regulatory Consultant
Phase I Unit Accreditation for FIH Studies in Malaysia
Nicholas Leow Chun Wei
NPRA, Malaysia
Head of Section GCP